International Peer-Reviewed Journal•Open Access•ISSN 2456-8880
irejournals@gmail.com•+91-7433024337

Home / Current Issue / Paper 1710671

1710671 Vol 2 · Issue 12 Download Paper

Assessing the Environmental and Public Health Risks of Improper Pharmaceutical Disposal

Omodolapo Eunice Ogunsola

Subject area: Biological & Medical Sciences  ·  Area of research: Environmental Health

Abstract

Improper pharmaceutical disposal poses significant threats to both environmental sustainability and public health. Pharmaceuticals discarded through household waste, sewage systems, and landfill leachates often enter surface and groundwater, leading to contamination of ecosystems and human food chains. This review explores the pathways through which pharmaceutical residues persist in the environment, their bioaccumulation in aquatic and terrestrial systems, and the associated risks to biodiversity and human health. Evidence highlights the emergence of antimicrobial resistance, endocrine disruption in wildlife, and adverse effects on water quality and agricultural productivity as major consequences of improper disposal. The paper also assesses current regulatory frameworks and disposal practices, identifying gaps in public awareness, waste management infrastructure, and enforcement mechanisms. Finally, it proposes integrated strategies?including pharmaceutical take-back programs, improved wastewater treatment technologies, and community-based awareness initiatives?to mitigate risks and promote sustainable disposal practices. By examining the environmental and public health implications of pharmaceutical waste, this study underscores the urgent need for multi-sectoral collaboration and policy innovation to safeguard ecosystems and human well-being.

Keywords

Pharmaceutical Waste, Environmental Contamination, Public Health Risks, Antimicrobial Resistance, Waste Management, Sustainable Disposal.

References

[1] Adenuga, T., Ayobami, A.T. & Okolo, F.C., 2019. Laying the Groundwork for Predictive Workforce Planning Through Strategic Data Analytics and Talent Modeling. IRE Journals, 3(3), pp.159–161. ISSN: 2456-8880.

[2] Anyebe, N. B., Dimkpa, C., Aboki, D., Egbule, D., Useni, S., & Eneogu, R. (2018). Impact of active case finding of tuberculosis among prisoners using the WOW truck in North central Nigeria. The international Union Against Tuberculosis and Lung Disease, 11, 22.

[3] aus der Beek, T., & Küster, A. (2017). Pharmaceutical risk assessment: Challenges in the context of environmental risk. Chemosphere, 188, 821–829.

[4] aus der Beek, T., & Küster, A. (2019). Linking pharmaceutical regulation and environmental protection: Societal and economic dimensions. Ecological Economics, 164, 106335. https://doi.org/10.1016/j.ecolecon.2019.106335

[5] aus der Beek, T., & Rösch, A. (2018). Pharmaceuticals and personal care products in the environment: A review on exposure pathways, fate, and effects. Science of the Total Environment, 645, 820–841. https://doi.org/10.1016/j.scitotenv.2018.07.173

[6] aus der Beek, T., Bergmann, A., Hickmann, S., Ebert, I., Hein, A., & Küster, A. (2018). Pharmaceuticals in surface and groundwater: Occurrence and environmental risk assessment. Environmental Pollution, 236, 825–841. https://doi.org/10.1016/j.envpol.2018.01.033

[7] aus der Beek, T., Kühnel, D., & Ricking, M. (2017). Environmental occurrence and toxicity of pharmaceuticals. Environmental Sciences Europe, 29(1), 20. https://doi.org/10.1186/s12302-017-0120-3

[8] Aus der Beek, T., Weber, F. A., Bergmann, A., Hickmann, S., Ebert, I., Hein, A., & Küster, A. (2018). Pharmaceuticals in the environment—Global occurrences and perspectives. Environmental Toxicology and Chemistry, 35(4), 823–835. https://doi.org/10.1002/etc.3339

[9] Bashaar, M., Thawani, V., Hassali, M. A., & Saleem, F. (2017). Disposal practices of unused and expired pharmaceuticals among general public in Kabul. BMC Public Health, 17(1), 45–52. https://doi.org/10.1186/s12889-016-3975-y

[10] Boxall, A. B. A., Rudd, M. A., Brooks, B. W., Caldwell, D. J., Choi, K., Hickmann, S., ... & Van Der Kraak, G. (2012). Pharmaceuticals and personal care products in the environment: What are the big questions? Environmental Health Perspectives, 120(9), 1221–1229.

[11] Boxall, A., Rudd, M. A., Brooks, B. W., Caldwell, D. J., Choi, K., Hickmann, S., … & Van Der Kraak, G. (2018). Pharmaceuticals in the environment: Global occurrence and potential for risk management. Philosophical Transactions of the Royal Society B: Biological Sciences, 369(1656), 20130571. https://doi.org/10.1098/rstb.2013.0571

[12] Daughton, C. G. (2018). Pharmaceuticals and the environment: Stewardship for sustainability. Environmental Health Perspectives, 126(8), 084501. https://doi.org/10.1289/EHP2753

[13] Daughton, C. G. (2019). Pharmaceuticals and the environment (PiE): Evolution and impact of the published literature revealed by bibliometric analysis. Science of the Total Environment, 562, 391–426. https://doi.org/10.1016/j.scitotenv.2016.03.109

[14] Evans-Uzosike, I.O. & Okatta, C.G., 2019. Strategic Human Resource Management: Trends, Theories, and Practical Implications. Iconic Research and Engineering Journals, 3(4), pp.264-270.

[15] Fatta-Kassinos, D., Meric, S., & Nikolaou, A. (2011). Pharmaceutical residues in environmental waters and wastewater: Current state of knowledge and future research. Analytical and Bioanalytical Chemistry, 399(1), 251–275.

[16] Heath, E., & Filipič, M. (2021). Human exposure to residues of pharmaceuticals in the environment. Environment International, 146, 106227. https://doi.org/10.1016/j.envint.2020.106227

[17] Hughes, S. R., Kay, P., & Brown, L. E. (2013). Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environmental Science & Technology, 47(2), 661–677. https://doi.org/10.1021/es3030148

[18] Ibitoye, B. A., AbdulWahab, R., & Mustapha, S. D. (2017). Estimation of drivers’ critical gap acceptance and follow-up time at four–legged unsignalized intersection. CARD International Journal of Science and Advanced Innovative Research, 1(1), 98-107.

[19] Jobling, S., Burn, R. W., Thorpe, K., Williams, R., & Tyler, C. (2018). Statistical modeling suggests that antiandrogens in effluents from wastewater treatment works contribute to widespread sexual disruption in fish living in English rivers. Environmental Health Perspectives, 126(5), 057006. https://doi.org/10.1289/EHP2693

[20] Kidd, K. A., Paterson, M. J., Rennie, M. D., Podemski, C. L., Findlay, D. L., Blanchfield, P. J., & Liber, K. (2017). Direct and indirect responses of a freshwater food web to a potent synthetic oestrogen. Philosophical Transactions of the Royal Society B: Biological Sciences, 372(1712), 20160121. https://doi.org/10.1098/rstb.2016.0121

[21] Kim, K. Y., Park, H., & Lee, H. J. (2018). Human exposure to endocrine-disrupting chemicals and their effect on health. Journal of Preventive Medicine and Public Health, 51(6), 365–372. https://doi.org/10.3961/jpmph.18.101

[22] Kookana, R. S., Williams, M., Boxall, A. B., Larsson, D. G., Gaw, S., Choi, K., ... & Yamamoto, H. (2014). Potential ecological footprints of active pharmaceutical ingredients: An examination of risk factors in low-, middle- and high-income countries. Philosophical Transactions of the Royal Society B: Biological Sciences, 369(1656), 20130586. https://doi.org/10.1098/rstb.2013.0586

[23] Kumar, A., Xagoraraki, I., & Choi, S. (2017). Human health risk assessment of antibiotics in water: Implications of resistant bacteria. Water Research, 123, 448–458. https://doi.org/10.1016/j.watres.2017.06.042

[24] Kümmerer, K. (2017). Antibiotics in the aquatic environment–A review–Part I. Chemosphere, 75(4), 417–434. https://doi.org/10.1016/j.chemosphere.2008.11.086

[25] Kümmerer, K. (2017). Concepts of sustainable pharmacy and pharmaceutically active compounds in the environment. Environmental Science and Pollution Research, 24(5), 1–9. https://doi.org/10.1007/s11356-016-6855-4

[26] Kümmerer, K. (2017). Sustainable chemistry and pharmacy of pharmaceuticals in the environment. Angewandte Chemie International Edition, 56(49), 15246–15251. https://doi.org/10.1002/anie.201703864

[27] Kümmerer, K., Dionysiou, D. D., Olsson, O., & Fatta-Kassinos, D. (2018). A path to clean water: Pharmaceuticals in the environment. Nature Sustainability, 1(11), 636–643. https://doi.org/10.1038/s41893-018-0152-0

[28] Kümmerer, K., Dionysiou, D. D., Olsson, O., & Fatta-Kassinos, D. (2018). A path to clean water: Pharmaceuticals in the environment—Global occurrence and potential solutions. Chemosphere, 201, 1–19. https://doi.org/10.1016/j.chemosphere.2018.02.219

[29] Kümmerer, K., Dionysiou, D. D., Olsson, O., & Fatta-Kassinos, D. (2018). A path to clean water: Pharmaceuticals in the environment. Nature Sustainability, 1, 309–315. https://doi.org/10.1038/s41893-018-0070-2

[30] Kuspis, D. A., & Krenzelok, E. P. (2019). What happens to expired medications? A survey of patient disposal practices. Journal of Clinical Pharmacy and Therapeutics, 44(1), 99–104. https://doi.org/10.1111/jcpt.12730

[31] Kusturica, M. P., Tomas, A., & Sabo, A. (2017). Disposal of unused drugs: Knowledge and behavior among people around the world. Reviews of Environmental Contamination and Toxicology, 240, 71–104. https://doi.org/10.1007/398_2016_3

[32] Larsson, D. G. J. (2014). Pollution from drug manufacturing: Review and perspectives. Philosophical Transactions of the Royal Society B: Biological Sciences, 369(1656), 20130571. https://doi.org/10.1098/rstb.2013.0571

[33] Michael, I., Rizzo, L., McArdell, C. S., Manaia, C. M., Merlin, C., Schwartz, T., Dagot, C., & Fatta-Kassinos, D. (2013). Urban wastewater treatment plants as hotspots for antibiotic-resistant bacteria and genes spread into the environment: A review. Science of the Total Environment, 447, 345–360. https://doi.org/10.1016/j.scitotenv.2013.01.032

[34] Miller, T. H., Ng, K. T., Bury, N. R., & Owen, S. F. (2018). Linking in vitro and in vivo data for pharmaceutical risk assessment in aquatic systems. Environment International, 113, 113–126.

[35] Murray, K. E., Thomas, S. M., & Bodour, A. A. (2017). Prioritizing research for trace pollutants and emerging contaminants in the freshwater environment. Environmental Pollution, 158(12), 3462–3471. https://doi.org/10.1016/j.envpol.2010.08.009

[36] Nwaimo, C.S., Oluoha, O.M. & Oyedokun, O., 2019. Big Data Analytics: Technologies, Applications, and Future Prospects. IRE Journals, 2(11), pp.411–419. DOI: 10.46762/IRECEE/2019.51123.

[37] Oyedokun, O.O., 2019.Green Human Resource Management Practices (GHRM) and Its Effect on Sustainable Competitive Edge in the Nigerian Manufacturing Industry: A Study of Dangote Nigeria Plc. MBA Dissertation, Dublin Business School.

[38] Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman Jr, C. U., & Mohan, D. (2019). Pharmaceuticals of emerging concern in aquatic systems: Chemistry, occurrence, effects, and removal methods. Chemosphere, 222, 505–526. https://doi.org/10.1016/j.chemosphere.2019.01.107

[39] Pruden, A., Larsson, D. G. J., Amézquita, A., Collignon, P., Brandt, K. K., Graham, D. W., ... & Zhu, Y. G. (2013). Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environmental Health Perspectives, 121(8), 878–885. https://doi.org/10.1289/ehp.1206446

[40] Seehusen, D. A., & Edwards, J. (2018). Patient practices and beliefs concerning disposal of medications. Journal of the American Board of Family Medicine, 19(6), 542–547. https://doi.org/10.3122/jabfm.19.6.542

[41] Sharma, A., Adekunle, B.I., Ogeawuchi, J.C., Abayomi, A.A. & Onifade, O. (2019) 'IoT-enabled Predictive Maintenance for Mechanical Systems: Innovations in Real-time Monitoring and Operational Excellence', IRE Journals, 2(12), pp. 1-10.

[42] Tong, A. Y. C., Peake, B. M., & Braund, R. (2011). Disposal practices for unused medications around the world. Environment International, 37(1), 292–298. https://doi.org/10.1016/j.envint.2010.10.002

[43] Verlicchi, P., & Zambello, E. (2015). Pharmaceuticals and personal care products in untreated and treated sewage sludge: Occurrence and environmental risk in the case of application on soil—A critical review. Science of the Total Environment, 538, 750–767. https://doi.org/10.1016/j.scitotenv.2015.08.108

[44] Verlicchi, P., Al Aukidy, M., & Zambello, E. (2015). Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after secondary treatment—A review. Science of The Total Environment, 429, 123–155. https://doi.org/10.1016/j.scitotenv.2012.04.040

[45] Wang, Y., & Wang, Y. (2019). Endocrine disrupting chemicals and human health: An evidence-based perspective. Ecotoxicology and Environmental Safety, 176, 1–9. https://doi.org/10.1016/j.ecoenv.2019.03.089

[46] Wellington, E. M., Boxall, A. B., Cross, P., Feil, E. J., Gaze, W. H., Hawkey, P. M., ... & Wooldridge, M. (2013). The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. The Lancet Infectious Diseases, 13(2), 155–165. https://doi.org/10.1016/S1473-3099(12)70317-1

[47] WHO. (2019). Global report on effective access to assistive technology. World Health Organization. Retrieved from https://www.who.int/publications/i/item/9789241517032

[48] Wilkinson, J. L., Boxall, A. B. A., Kolpin, D. W., Leung, K. M. Y., Lai, R. W. S., Galbán-Malagón, C., ... & Lam, P. K. S. (2017). Pharmaceutical pollution of the world’s rivers. Proceedings of the National Academy of Sciences, 119(8), e2113947119. https://doi.org/10.1073/pnas.2113947119

[49] Wilkinson, J. L., Hooda, P. S., Barker, J., Barton, S., & Swinden, J. (2018). Occurrence, fate and transformation of emerging contaminants in water: An overarching review of the field. Environmental Pollution, 236, 954–970. https://doi.org/10.1016/j.envpol.2018.02.034

[50] Zhang, Q. Q., Ying, G. G., Pan, C. G., Liu, Y. S., & Zhao, J. L. (2015). Comprehensive evaluation of antibiotics emission and fate in the river basins of China: Source analysis, multimedia modeling, and linkage to bacterial resistance. Environmental Science & Technology, 49(11), 6772–6782. https://doi.org/10.1021/acs.est.5b00729

How to cite this paper

Omodolapo Eunice Ogunsola "Assessing the Environmental and Public Health Risks of Improper Pharmaceutical Disposal" Iconic Research And Engineering Journals Volume 2 Issue 12 2019 Page 394-407
Omodolapo Eunice Ogunsola "Assessing the Environmental and Public Health Risks of Improper Pharmaceutical Disposal" Iconic Research And Engineering Journals, vol. 2, no. 12, Jun. 2019
Omodolapo Eunice Ogunsola (2019). Assessing the Environmental and Public Health Risks of Improper Pharmaceutical Disposal. Iconic Research And Engineering Journals, 2(12).
Omodolapo Eunice Ogunsola "Assessing the Environmental and Public Health Risks of Improper Pharmaceutical Disposal" Iconic Research And Engineering Journals, vol. 2, no. 12, Jun. 2019.
@article{1710671,
      author = {Omodolapo Eunice Ogunsola},
      title = {Assessing the Environmental and Public Health Risks of Improper Pharmaceutical Disposal},
      journal = {Iconic Research And Engineering Journals},
      year = {2019},
      volume = {2},
      number = {12},
      pages = {394-407},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1710671.pdf},
      abstract = {Improper pharmaceutical disposal poses significant threats to both environmental sustainability and public health. Pharmaceuticals discarded through household waste, sewage systems, and landfill leachates often enter surface and groundwater, leading to contamination of ecosystems and human food chains. This review explores the pathways through which pharmaceutical residues persist in the environment, their bioaccumulation in aquatic and terrestrial systems, and the associated risks to biodiversity and human health. Evidence highlights the emergence of antimicrobial resistance, endocrine disruption in wildlife, and adverse effects on water quality and agricultural productivity as major consequences of improper disposal. The paper also assesses current regulatory frameworks and disposal practices, identifying gaps in public awareness, waste management infrastructure, and enforcement mechanisms. Finally, it proposes integrated strategies?including pharmaceutical take-back programs, improved wastewater treatment technologies, and community-based awareness initiatives?to mitigate risks and promote sustainable disposal practices. By examining the environmental and public health implications of pharmaceutical waste, this study underscores the urgent need for multi-sectoral collaboration and policy innovation to safeguard ecosystems and human well-being.},
      keywords = {Pharmaceutical Waste, Environmental Contamination, Public Health Risks, Antimicrobial Resistance, Waste Management, Sustainable Disposal.},
      month = {June},
  }